These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 817606)

  • 21. Genetic variants of hexosaminidase deficiency.
    Patrick AD
    Prog Clin Biol Res; 1977; 18():147-59. PubMed ID: 414238
    [No Abstract]   [Full Text] [Related]  

  • 22. [Identification of GM2-gangliosidosis using an in vitro loading test].
    Akhunov VS; Krasnopol'skaia KD
    Vopr Med Khim; 1987; 33(4):115-9. PubMed ID: 3116767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats.
    Yamato O; Matsunaga S; Takata K; Uetsuka K; Satoh H; Shoda T; Baba Y; Yasoshima A; Kato K; Takahashi K; Yamasaki M; Nakayama H; Doi K; Maede Y; Ogawa H
    Vet Rec; 2004 Dec; 155(23):739-44. PubMed ID: 15623087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [GM2 activator protein deficiency (AB variant form of GM2 gangliosidosis)].
    Kondoh K; Sano A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):411-3. PubMed ID: 9645095
    [No Abstract]   [Full Text] [Related]  

  • 25. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biosynthesis and biodegradation of GM2 ganglioside].
    Hirabayashi Y; Kasakura H; Matsumoto M
    Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
    [No Abstract]   [Full Text] [Related]  

  • 29. Oligosaccharide storage in brains from patients with fucosidosis, GM1-gangliosidosis and GM2-gangliosidosis (Sandhoff's disease).
    Tsay GC; Dawson G
    J Neurochem; 1976 Sep; 27(3):733-40. PubMed ID: 823301
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomedical genetics of the inherited metabolic diseases: the GM2-gangliosidoses.
    Kolodny EH
    Am J Ment Defic; 1984 Mar; 88(5):582-9. PubMed ID: 6428229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.
    Van Cong N; Weil D; Rebourcet R; Frézal J; Richard-Mollard AM
    Ann Hum Genet; 1975 Jul; 39(1):111-23. PubMed ID: 810068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis.
    Renshaw PF; Stern TA; Welch C; Schouten R; Kolodny EH
    Ann Neurol; 1992 Mar; 31(3):342-4. PubMed ID: 1386210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tay-Sachs and Sandhoff diseases: an hypothesis about the primary lesion based on hexosaminidase patterns in interspecific hybrids.
    Van Cong N; Weil D; Rebourcet R; Pangalos C; Frézal J
    Birth Defects Orig Artic Ser; 1975; 11(3):272-5. PubMed ID: 812570
    [No Abstract]   [Full Text] [Related]  

  • 34. Substrate specificity of hexosaminidase A isolated from the liver of a patient with a rare form (AB variant) of infantile GM2 gangliosidosis and control tissues.
    Sandhoff K; Conzelmann E; Nehrkorn H
    Adv Exp Med Biol; 1978; 101():727-30. PubMed ID: 96668
    [No Abstract]   [Full Text] [Related]  

  • 35. GM1 gangliosidosis: phenotypic variation in a single family.
    Farrell DF; Ochs U
    Ann Neurol; 1981 Mar; 9(3):225-31. PubMed ID: 6784662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
    Pullarkat RK; Reha H; Beratis NG
    Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oculomotor abnormalities in chronic GM2 gangliosidosis.
    Musarella MA; Raab EL; Rudolph SH; Grabowski GA; Desnick RJ
    J Pediatr Ophthalmol Strabismus; 1982; 19(2):80-9. PubMed ID: 6808109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete localization of disulfide bonds in GM2 activator protein.
    Schütte CG; Lemm T; Glombitza GJ; Sandhoff K
    Protein Sci; 1998 Apr; 7(4):1039-45. PubMed ID: 9568910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of AB variant, GM2 gangliosidosis.
    Kotagal S
    Ann Neurol; 1986 Jan; 19(1):102. PubMed ID: 3080943
    [No Abstract]   [Full Text] [Related]  

  • 40. GM1-generalized gangliosidosis variant with cardiomegaly.
    Benson PF; Barbarik A; Brown SP; Mann TP
    Postgrad Med J; 1976 Mar; 52(605):159-65. PubMed ID: 131309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.